Marico raises stake in Satiya Nutraceuticals

All-cash acquisition worth ₹1,012.03 crore

0
5
Marico bought an additional 24.09% stake from Plix's founders Rishubh Satiya and Akash Zaveri and other key shareholders.
Marico bought an additional 24.09% stake from Plix's founders Rishubh Satiya and Akash Zaveri and other key shareholders.

FMCG major Marico Limited has raised its stake in Satiya Nutraceuticals, the parent company of plant-based health and wellness brand Plix, to 84.09% following an all-cash acquisition worth ₹1,012.03 crore. This latest transaction was executed on 5 October 2026, increasing Marico’s holdings from its previous 60% share, media reports stated.

Marico bought an additional 24.09% stake from Plix’s founders Rishubh Satiya and Akash Zaveri and other key shareholders. With this transaction, Marico’s total investment for its 84.09% holding in Satiya Nutraceuticals stands at ₹1,392.07 crore.

The acquisition is part of a larger agreement to take over 38.18% in tranches. The remaining 14.09% stake is scheduled to be acquired in July 2027 for a base consideration of up to ₹592 crore alongside milestone-linked payments.

Satiya Nutraceuticals has reported sharp growth in consolidated turnover over the past three financial years. Revenue rose to Rs 864.31 crore in FY2025-26 from Rs 432.84 crore in FY2024-25 and Rs 155.32 crore in FY2023-24.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This function has been disabled for HealthTekPack.

error: Content is protected !!